MedCity Influencers

T2 Biosystems hires UK firm to help develop portable diagnostic system

T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the development of its portable diagnostics system. The Cambridge, Massachusetts-based start-up is developing nano- and miniaturized magnetic resonance-based technology for use in a bench-top instrument for small molecule diagnostics, according to Sagentia. In May, T2 raised $15 million in a Series C funding […]

T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the development of its portable diagnostics system.

The Cambridge, Massachusetts-based start-up is developing nano- and miniaturized magnetic resonance-based technology for use in a bench-top instrument for small molecule diagnostics, according to Sagentia.

In May, T2 raised $15 million in a Series C funding round to support the development of the technology.

The use of MR technology is faster, more reliable and may be less expensive for both molecular and immunodiagnostics applications because it requires less processing than optical-based diagnostic tool require, according to Sagentia.

T2‘s technology “will offer improved speed, accuracy and efficiency as well as portability to a broader range of settings including doctors’ offices, homes and hospitals,” Sagentia CEO Brent Hudson said in prepared remarks. “This project also clearly reflects the wider trend we are seeing towards growth in the point of care diagnostics market,” he said.

In November, Sagentia opened up a location in Cambridge, Massachusetts, less than one mile from T2’s headquarters.

Specific terms of the deal were not released.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.